These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 28128443)
1. Potential Therapeutic Applications of Adenosine A van Waarde A; Dierckx RAJO; Zhou X; Khanapur S; Tsukada H; Ishiwata K; Luurtsema G; de Vries EFJ; Elsinga PH Med Res Rev; 2018 Jan; 38(1):5-56. PubMed ID: 28128443 [TBL] [Abstract][Full Text] [Related]
2. Adenosine A2A Receptor as a Potential Drug Target - Current Status and Future Perspectives. Al-Attraqchi OHA; Attimarad M; Venugopala KN; Nair A; Al-Attraqchi NHA Curr Pharm Des; 2019; 25(25):2716-2740. PubMed ID: 31333093 [TBL] [Abstract][Full Text] [Related]
3. Allosteric Interactions between Adenosine A Prasad K; de Vries EFJ; Elsinga PH; Dierckx RAJO; van Waarde A Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33572077 [TBL] [Abstract][Full Text] [Related]
4. Adenosine A2A receptor as a drug discovery target. de Lera Ruiz M; Lim YH; Zheng J J Med Chem; 2014 May; 57(9):3623-50. PubMed ID: 24164628 [TBL] [Abstract][Full Text] [Related]
5. Preclinical Evaluation and Quantification of Khanapur S; van Waarde A; Dierckx RA; Elsinga PH; Koole MJ J Nucl Med; 2017 Mar; 58(3):466-472. PubMed ID: 27789720 [TBL] [Abstract][Full Text] [Related]
6. A2A Adenosine Receptor Agonists and their Potential Therapeutic Applications. An Update. Guerrero A Curr Med Chem; 2018; 25(30):3597-3612. PubMed ID: 29532748 [TBL] [Abstract][Full Text] [Related]
10. Vuorimaa A; Rissanen E; Airas L Contrast Media Mol Imaging; 2017; 2017():6975841. PubMed ID: 29348737 [TBL] [Abstract][Full Text] [Related]
11. In vivo evaluation of [ Zhou X; Khanapur S; de Jong JR; Willemsen AT; Dierckx RA; Elsinga PH; de Vries EF J Cereb Blood Flow Metab; 2017 Feb; 37(2):577-589. PubMed ID: 26917190 [TBL] [Abstract][Full Text] [Related]
12. Integrating Pharmacophore into Membrane Molecular Dynamics Simulations to Improve Homology Modeling of G Protein-coupled Receptors with Ligand Selectivity: A2A Adenosine Receptor as an Example. Zeng L; Guan M; Jin H; Liu Z; Zhang L Chem Biol Drug Des; 2015 Dec; 86(6):1438-50. PubMed ID: 26072970 [TBL] [Abstract][Full Text] [Related]
14. First visualization of adenosine A(2A) receptors in the human brain by positron emission tomography with [11C]TMSX. Ishiwata K; Mishina M; Kimura Y; Oda K; Sasaki T; Ishii K Synapse; 2005 Feb; 55(2):133-6. PubMed ID: 15543628 [TBL] [Abstract][Full Text] [Related]
15. 5-Substituted 2-benzylidene-1-tetralone analogues as A Janse van Rensburg HD; Terre'Blanche G; van der Walt MM; Legoabe LJ Bioorg Chem; 2017 Oct; 74():251-259. PubMed ID: 28881253 [TBL] [Abstract][Full Text] [Related]
16. Novel approaches for targeting the adenosine A2A receptor. Yuan G; Gedeon NG; Jankins TC; Jones GB Expert Opin Drug Discov; 2015 Jan; 10(1):63-80. PubMed ID: 25311639 [TBL] [Abstract][Full Text] [Related]
17. Allosteric Modulation of Adenosine A Korkutata M; Agrawal L; Lazarus M Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216213 [TBL] [Abstract][Full Text] [Related]
18. Immune Alterations in CD8 Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Mohammad R; Attia SM Mol Neurobiol; 2018 Mar; 55(3):2603-2616. PubMed ID: 28421534 [TBL] [Abstract][Full Text] [Related]
19. An example of the clinical selectivity of regadenoson for the A2a adenosine receptor. Miyamoto MI; Clarke KA; Thomas GS; Belardinelli L Am Heart Hosp J; 2009; 7(2):E118-21. PubMed ID: 20354957 [No Abstract] [Full Text] [Related]
20. Overcoming the blood-brain barrier for delivering drugs into the brain by using adenosine receptor nanoagonist. Gao X; Qian J; Zheng S; Changyi Y; Zhang J; Ju S; Zhu J; Li C ACS Nano; 2014 Apr; 8(4):3678-89. PubMed ID: 24673594 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]